Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists.

McMahon AW, Levenson MS, McEvoy BW, Mosholder AD, Murphy D.

Pediatrics. 2011 Nov;128(5):e1147-54. doi: 10.1542/peds.2010-1720. Epub 2011 Oct 24. Review.

PMID:
22025595
2.

Long-acting β2-agonist step-off in patients with controlled asthma.

Brozek JL, Kraft M, Krishnan JA, Cloutier MM, Lazarus SC, Li JT, Santesso N, Strunk RC, Casale TB.

Arch Intern Med. 2012 Oct 8;172(18):1365-75. Review.

PMID:
22928176
3.

Adverse effects of beta-agonists: are they clinically relevant?

Abramson MJ, Walters J, Walters EH.

Am J Respir Med. 2003;2(4):287-97. Review.

PMID:
14719995
4.

Evaluating safety of long-acting beta agonists (LABAs) in patients with asthma.

Bian B, Kelton CM, Wigle PR, Guo JJ.

Curr Drug Saf. 2010 Jul 2;5(3):245-50. Review.

PMID:
20210730
5.

Safety of long-acting beta-agonists: are new data really required?

Sears MR.

Chest. 2009 Aug;136(2):604-607. doi: 10.1378/chest.09-1214. Epub 2009 Jun 8. Review.

PMID:
19505986
6.

Safety of formoterol in children and adolescents: experience from asthma clinical trials.

Price JF, Radner F, Lenney W, Lindberg B.

Arch Dis Child. 2010 Dec;95(12):1047-53. doi: 10.1136/adc.2010.183814. Epub 2010 Oct 27. Review.

PMID:
21030368
7.

The risk of asthma mortality with inhaled long acting beta-agonists.

Wijesinghe M, Perrin K, Harwood M, Weatherall M, Beasley R.

Postgrad Med J. 2008 Sep;84(995):467-72. doi: 10.1136/pgmj.2007.067165. Review.

PMID:
18940948
8.

LABAs in asthmatic children: highlights and new inside.

Miraglia del Giudice M, Matera MG, Capristo C, Conte M, Santaniello F, Chinellato I, Leonardi S, Miraglia del Giudice MC, Perrone L.

Pulm Pharmacol Ther. 2013 Oct;26(5):540-3. doi: 10.1016/j.pupt.2013.04.002. Epub 2013 Apr 11. Review.

PMID:
23583567
9.

Beta-2 adrenergic agonists: focus on safety and benefits versus risks.

Ortega VE, Peters SP.

Curr Opin Pharmacol. 2010 Jun;10(3):246-53. doi: 10.1016/j.coph.2010.04.009. Epub 2010 May 6. Review.

PMID:
20452285
11.

Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies.

Hernández G, Avila M, Pont A, Garin O, Alonso J, Laforest L, Cates CJ, Ferrer M; ASTRO-LAB group.

Respir Res. 2014 Jul 19;15:83. doi: 10.1186/1465-9921-15-83. Review.

12.

[Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].

Buhl R.

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S381-5. doi: 10.1055/s-0029-1243046. Epub 2009 Nov 25. Review. German. No abstract available.

PMID:
19941241
13.

The β-2 agonist debate: is there still a problem?

Patel M, Shirtcliffe P, Beasley R.

Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):58-62. doi: 10.1097/ACI.0b013e32835a5ad9. Review.

PMID:
23037719
14.

Are inhaled longacting β2 agonists detrimental to asthma?

Cockcroft DW, Sears MR.

Lancet Respir Med. 2013 Jun;1(4):339-46. doi: 10.1016/S2213-2600(13)70044-4. Epub 2013 May 9. Review.

PMID:
24429159
15.

A systematic review of adverse drug events associated with administration of common asthma medications in children.

Leung JS, Johnson DW, Sperou AJ, Crotts J, Saude E, Hartling L, Stang A.

PLoS One. 2017 Aug 9;12(8):e0182738. doi: 10.1371/journal.pone.0182738. eCollection 2017. Review.

16.

Assessing the viability of long-acting β2-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective.

Matera MG, Rinaldi B, Calzetta L, Cazzola M.

Expert Opin Drug Metab Toxicol. 2017 Feb;13(2):129-136. doi: 10.1080/17425255.2017.1234604. Epub 2016 Sep 14. Review.

PMID:
27615145
17.

Management of asthma in school-aged children and adolescents.

Durrani S.

Pediatr Ann. 2014 Aug;43(8):e184-91. doi: 10.3928/00904481-20140723-08. Review.

PMID:
25102488
18.

Pharmacogenomics of long-acting β2-agonists.

Blake K, Lima J.

Expert Opin Drug Metab Toxicol. 2015;11(11):1733-51. doi: 10.1517/17425255.2015.1071793. Epub 2015 Aug 3. Review.

PMID:
26235677
19.

[Risk of long-acting beta-2 agonists in asthma].

Orriols R, Vallano A.

Med Clin (Barc). 2007 Mar 10;128(9):352-4. Review. Spanish. No abstract available.

PMID:
17376363
20.

Concerns with beta2-agonists in pediatric asthma - a clinical perspective.

Kersten ET, Koppelman GH, Thio BJ.

Paediatr Respir Rev. 2017 Jan;21:80-85. doi: 10.1016/j.prrv.2016.05.006. Epub 2016 Jun 16. Review.

PMID:
27515731

Supplemental Content

Support Center